Name: Ethical Perspectives on Artificial Intelligence in Biomedical Engineering (en Inglés)
SKU: 66200838
Price: 68.57 USD
Availability: InStock
Author: Manzeschke, Prof Dr Theol Habil Arne; Wittenberg, Dr -Ing Thomas; Manzeschke, Arne

portada Ethical Perspectives on Artificial Intelligence in Biomedical Engineering (en Inglés)

Ethical Perspectives on Artificial Intelligence in Biomedical Engineering (en Inglés)

Formato

Libro Físico

Editorial

de Gruyter

Autor

Manzeschke, Prof Dr Theol Habil Arne; Wittenberg, Dr -Ing Thomas; Manzeschke, Arne

Idioma

Inglés

N° páginas

916

Encuadernación

Tapa Dura

Dimensiones

24.4x17x2.5 cm

ISBN13

9783111586199

Ethical Perspectives on Artificial Intelligence in Biomedical Engineering (en Inglés)

Manzeschke, Prof Dr Theol Habil Arne; Wittenberg, Dr -Ing Thomas; Manzeschke, Arne (Autor) · de Gruyter · Tapa Dura

Libro Nuevo Importado

Envío: 15 a 22 días háb.

$ 137.14$ 68.57

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 81 unidades

$ 68.57

Llega entre el 17 Sep y el 30 Sep a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Ethical Perspectives on Artificial Intelligence in Biomedical Engineering (en Inglés)"

Artificial intelligence (AI) is currently considered a disruptive key technology in the field of biomedical engineering. However, there is more to it than just the applications, advantages and challenges of AI in this field. The book takes a closer look at various additional aspects and provides a more comprehensive view of AI in healthcare.The first part provides introductory considerations from a historical, technical, socio-scientific, legal and ethical perspectives. Complementing this, the second part illustrates these topics using various applications in the field of biomedical engineering. These cannot be covered exhaustively, but a broad overview is provided and the relevant challenges are addressed. Finally, the last part deals with questions relating to the framework conditions, the regulation of AI and the associated business models.Last but not least, brief introductory statements from the Federal Ministry of Research, Technology and Space and the DGBMT on the topic of AI in biotechnology and healthcare underscore the relevance of the contributions.